Yes, it’s funny how many small medical treatment companies have managed to obtain full approvals for their products. Amazing really.
The devotees work themselves up into a rich lather over the rejection of the cancer application because they failed to undertake proper trials and instead elected to go down the “big wig” promotion course. Regardless of the strong hints from the FDA that trials were needed.
Then, there’s the failure to obtain an EUA for the Covid application. There’s a bunch of posters distasteful counting of fatalities as some sort of internal justification. But, never a question is raised about Novartis disappearing off the face of the MSB earth, or the fact there is no EUA for a alleged miracle cure in the biggest health crisis in 100 years.
If your not approved an EUA in those circumstances, then forget it. Rather, the FDA says go and do a trial. There’s confidence.
Oh yes, it’s much better to chant “big announcement is due” over and over again.
- Forums
- ASX - By Stock
- MSB
- MSB - A Question of Trust?
MSB - A Question of Trust?, page-246
-
-
- There are more pages in this discussion • 52 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.32 |
Change
-0.025(1.86%) |
Mkt cap ! $1.507B |
Open | High | Low | Value | Volume |
$1.35 | $1.35 | $1.31 | $2.699M | 2.040M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 34995 | $1.32 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.33 | 10374 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 34995 | 1.320 |
2 | 7237 | 1.315 |
9 | 55559 | 1.310 |
5 | 117360 | 1.305 |
12 | 113507 | 1.300 |
Price($) | Vol. | No. |
---|---|---|
1.325 | 10374 | 2 |
1.330 | 11204 | 5 |
1.335 | 66318 | 6 |
1.340 | 16284 | 1 |
1.345 | 44067 | 2 |
Last trade - 16.10pm 31/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
Harsh Shethia, Advisor
Harsh Shethia
Advisor
SPONSORED BY The Market Online